• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

Prenetics Makes Strategic Shift to Bitcoin by Selling Genomics Unit

user avatar

by Giorgi Kostiuk

5 days ago


Prenetics Global Limited has announced the sale of its $70 million genomics division to focus on enhancing its Bitcoin investments.

Shift from Genomics to Bitcoin

Prenetics has decided to divest its genomics business to invest significantly in Bitcoin. Led by CEO Danny Yeung, the company aims to build a substantial Bitcoin treasury, drawing inspiration from firms like MicroStrategy.

CEO Danny Yeung expressed excitement about the merging of healthcare innovation and blockchain technology. The firm's board has approved a major Bitcoin acquisition strategy, seeking to establish the largest Bitcoin treasury in the healthcare sector.

"What excites me most is the convergence we're witnessing between healthcare innovation and blockchain technology. We're at the dawn of a new era where genomics, personalized medicine, and digital assets will intersect in ways that could revolutionize how we approach human health, longevity, and wealth. To execute this vision at scale, we need substantial Bitcoin holdings – which is why we're building one of the most significant Bitcoin treasuries in healthcare." — Danny Yeung, CEO, Prenetics Global Limited

Industry Impact

This move follows precedents set by companies like MicroStrategy that have ramped up Bitcoin acquisitions. Prenetics’ activities could significantly impact the BTC market, considering its stated long-term accumulation intention.

As Prenetics divests its genomics assets, it highlights a broader trend of corporations embracing digital assets. Such steps typically enhance corporate value by attracting investors interested in cryptocurrency diversification.

Future Prospects

Potential outcomes include influencing the intersections of healthcare and blockchain as Prenetics develops Bitcoin-integrated platforms. If successful, the implications could extend beyond healthcare, affecting corporate strategies globally in relation to blockchain and Bitcoin.

Prenetics' approach to selling its genomics division and investing in Bitcoin could reshape the perception of the intersection between healthcare and digital assets, solidifying Bitcoin as a primary asset among firms in this industry.

0

Share

Other news

Fiserv to Introduce FIUSD — Solana Based Stablecoin for Institutional Clients

Fiserv has announced the launch of FIUSD, a stablecoin on Solana, targeted at institutional clients and enhancing its digital asset platform.

user avatarGiorgi Kostiuk

2 minutes ago

Mastering Options Trading: 11 Strategies for Steady Returns

Explore 11 risk-managed options strategies designed to generate steady income and protect capital.

user avatarGiorgi Kostiuk

2 minutes ago

Ethereum Analysis: Price, Market Capitalization, and Indicators

Exploring the current status of Ethereum, including price fluctuations, market capitalization, and indicators for 2025.

user avatarGiorgi Kostiuk

3 minutes ago

PEPE, BONK, and APORK: The Leading Tokens of the Week

The micro-cap token market is buzzing as PEPE, BONK, and newcomer APORK gain traction among traders.

user avatarGiorgi Kostiuk

3 minutes ago

SUI: Price Decline and User Activity in the Network

Analysis of the current state of SUI prices, declining trends, and network activity.

user avatarGiorgi Kostiuk

5 minutes ago

XRP: Price Holds Steady at $2, Possible Further Fluctuations

XRP price stabilizes at $2 after a dip. Key support and resistance levels remain under pressure.

user avatarGiorgi Kostiuk

6 minutes ago

dapp expert logo
© 2020-2025. DappExpert. All rights reserved.
© 2020-2025. DappExpert. All rights reserved.

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.